Mechanistic insight into inhibition of amyloid fibrillation of human serum albumin by Vildagliptin
Authors:
- 13 May 2022
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 216, 112563
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Simultaneous Measurement of Amyloid Fibril Formation by Dynamic Light Scattering and Fluorescence Reveals Complex Aggregation KineticsPLOS ONE, 2013
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrilsBiochemical and Biophysical Research Communications, 2011
- Testing the Right Target and Right Drug at the Right StageScience Translational Medicine, 2011
- Neurocognitive signs in prodromal Huntington disease.Neuropsychology, 2011
- Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current statusJournal of Chemical Biology, 2009
- Existence of Different Structural Intermediates on the Fibrillation Pathway of Human Serum AlbuminBiophysical Journal, 2009
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005
- Spectroscopic Analysis of Amyloid Fibril Formation in SH3‐DomainsJournal of Spectroscopy, 2003
- The interaction of a naphthalene dye with apomyoglobin and apohemoglobinJournal of Molecular Biology, 1965